These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Some indices of the functional state of the adrenal cortex and copper metabolism in patients with vitiligo]. Tadzhibaev TT Vestn Dermatol Venerol; 1971 Feb; 45(2):26-9. PubMed ID: 5563590 [No Abstract] [Full Text] [Related]
24. [Role of autosensitization in the pathogenesis of vitiligo]. Koshevenko IuN Vestn Dermatol Venerol; 1986; (9):46-9. PubMed ID: 3799051 [No Abstract] [Full Text] [Related]
25. [Metyrapone in the therapy of vitiligo]. Dolecek R Cas Lek Cesk; 1983 May; 122(18):564-7. PubMed ID: 6850733 [No Abstract] [Full Text] [Related]
26. [Vitiligo: its treatment with hypericin]. Fujii HM; Pedroza AR; González W Prensa Med Argent; 1966 Aug; 53(33):1812-7. PubMed ID: 5994110 [No Abstract] [Full Text] [Related]
28. Response of vitiligo to PUVA therapy in Saudi patients. Tallab T; Joharji H; Bahamdan K; Karkashan E; Mourad M; Ibrahim K Int J Dermatol; 2005 Jul; 44(7):556-8. PubMed ID: 15985023 [TBL] [Abstract][Full Text] [Related]
29. [Administration of metopirone in the treatment of vitiligo]. Dolecek R Cas Lek Cesk; 1968; 107(38):1183-5. PubMed ID: 5682345 [No Abstract] [Full Text] [Related]
30. Treatment of vitiligo with 1 percent solution of the sodium salt of meladinine using the ionophoresis technique. Badr Moawad M Dermatol Monatsschr; 1969; 155(6):388-94. PubMed ID: 5386750 [No Abstract] [Full Text] [Related]
32. [Somatotropic function of the hypophysis in hypofunction of the thyroid gland]. Balabolkin MI; Kliachko VR; Kalinin AP; Selishcheva RF; Kasatkin IuN Klin Med (Mosk); 1972 Mar; 50(3):41-4. PubMed ID: 5024828 [No Abstract] [Full Text] [Related]
33. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Passeron T; Ostovari N; Zakaria W; Fontas E; Larrouy JC; Lacour JP; Ortonne JP Arch Dermatol; 2004 Sep; 140(9):1065-9. PubMed ID: 15381545 [TBL] [Abstract][Full Text] [Related]
34. Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo. Lu-yan T; Wen-wen F; Lei-hong X; Yi J; Zhi-zhong Z Photodermatol Photoimmunol Photomed; 2006 Dec; 22(6):310-4. PubMed ID: 17100739 [TBL] [Abstract][Full Text] [Related]
35. [Functional state of the thyroid gland in patients with vitiligo]. Borisenko KK Vestn Dermatol Venerol; 1971 Jan; 45(1):42-5. PubMed ID: 5564067 [No Abstract] [Full Text] [Related]
36. [Treatment of vitiligo using oral Trisoralen]. Karadaglić D; Stefanović Z; Mijailović B Zb Vojnomed Akad; 1976; (18):74-6. PubMed ID: 1074341 [No Abstract] [Full Text] [Related]
37. [Etiopathogenesis of acquired vitiligo in the light of our studies]. Chorazak T; Rzempoluch E Przegl Dermatol; 1967; 54(5):549-55. PubMed ID: 6063831 [No Abstract] [Full Text] [Related]
38. [Current points of view on the therapy of vitiligo]. Ormea F Minerva Med; 1974 Apr; 65(30):1653-64. PubMed ID: 4833771 [No Abstract] [Full Text] [Related]
39. Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo. Goktas EO; Aydin F; Senturk N; Canturk MT; Turanli AY J Eur Acad Dermatol Venereol; 2006 May; 20(5):553-7. PubMed ID: 16684283 [TBL] [Abstract][Full Text] [Related]
40. Topical melagenine for repigmentation in twenty-two child patients with vitiligo on the scalp. Xu AE; Wei XD Chin Med J (Engl); 2004 Feb; 117(2):199-201. PubMed ID: 14975202 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]